433 related articles for article (PubMed ID: 25465599)
21. Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: relation with nephropathy.
Piwowar A; Knapik-Kordecka M; Buczyńska H; Warwas M
Arch Immunol Ther Exp (Warsz); 1999; 47(5):327-31. PubMed ID: 10604239
[TBL] [Abstract][Full Text] [Related]
22. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
Morii T; Fujita H; Narita T; Shimotomai T; Fujishima H; Yoshioka N; Imai H; Kakei M; Ito S
J Diabetes Complications; 2003; 17(1):11-5. PubMed ID: 12505750
[TBL] [Abstract][Full Text] [Related]
23. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
24. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
25. Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease.
Hong N; Lee M; Park S; Lee YH; Jin SM; Kim JH; Lee BW
Sci Rep; 2018 Apr; 8(1):6710. PubMed ID: 29712934
[TBL] [Abstract][Full Text] [Related]
26. Association between nonalbumin proteinuria and renal tubular damage of N-acetyl-β-d-glucosaminidase and its clinical relevance in patients with type 2 diabetes without albuminuria.
Han E; Kim MK; Lee YH; Kim HS; Lee BW
J Diabetes Complications; 2019 Mar; 33(3):255-260. PubMed ID: 30236543
[TBL] [Abstract][Full Text] [Related]
27. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
[TBL] [Abstract][Full Text] [Related]
28. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
[TBL] [Abstract][Full Text] [Related]
29. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
Minakami H
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
[TBL] [Abstract][Full Text] [Related]
31. Correlation between urinary activity of N-acetyl-beta-D-glucosaminidase (NAG) and albumin excretion rate in type II (non-insulin-dependent) diabetic subjects.
Perdichizzi G; Cucinotta D; Fera R; Di Cesare E; Campo S; Squadrito G
Acta Diabetol Lat; 1987; 24(2):149-55. PubMed ID: 3115019
[TBL] [Abstract][Full Text] [Related]
32. Increased collagen IV excretion in diabetes. A marker of compromised filtration function.
Cohen MP; Lautenslager GT; Shearman CW
Diabetes Care; 2001 May; 24(5):914-8. PubMed ID: 11347754
[TBL] [Abstract][Full Text] [Related]
33. Association between the Urinary N-acetyl-β-D-Glucosaminidase/Creatinine Ratio and Factors of the Metabolic Syndrome.
Lee E; Lee YK; Kang HJ
Ann Clin Lab Sci; 2018 Sep; 48(5):627-633. PubMed ID: 30373868
[TBL] [Abstract][Full Text] [Related]
34. Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus.
Kim HK; Lee M; Lee YH; Kang ES; Cha BS; Lee BW
Diabetes Metab J; 2022 Jan; 46(1):104-116. PubMed ID: 34253010
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
[TBL] [Abstract][Full Text] [Related]
36. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
[TBL] [Abstract][Full Text] [Related]
37. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
Khan S; Qayyum S; Khan MNA
J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
[TBL] [Abstract][Full Text] [Related]
38. Urinary transferrin excretion in type 1 (insulin-dependent) diabetes mellitus.
O'Donnell MJ; Martin P; Florkowski CM; Toop MJ; Chapman C; Holder R; Barnett AH
Diabet Med; 1991; 8(7):657-61. PubMed ID: 1833118
[TBL] [Abstract][Full Text] [Related]
39. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].
Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E
An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872
[TBL] [Abstract][Full Text] [Related]
40. [Urinary proteins in patients with diabetes mellitus].
Hofmann W; Guder WG
Klin Wochenschr; 1989; 67 Suppl 17():37-9. PubMed ID: 2472508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
